Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort

doi:10.3748/wjg.v19.i10.1602

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5914)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

439

HTML

3479

Figures (1-5)

175

Tables (1-2)

140

Sum=4233

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1006

Download

675

Sum=1681

Mar 14, 2013 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 14, 2013; 19(10): 1602-1610
Published online Mar 14, 2013. doi: 10.3748/wjg.v19.i10.1602

Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort

Nimzing Gwamzhi Ladep, Patricia Aladi Agaba, Oche Agbaji, Auwal Muazu, Placid Ugoagwu, Godwin Imade, Graham Cooke, Sheena McCormack, Simon David Taylor-Robinson, John Idoko, Phyllis Kanki

Nimzing Gwamzhi Ladep, Graham Cooke, Simon David Taylor-Robinson, Section of Hepatology, Department of Medicine, Imperial College London, St Mary’s Hospital Campus, London W2 1NY, United Kingdom

Patricia Aladi Agaba, Oche Agbaji, Auwal Muazu, Placid Ugoagwu, Godwin Imade, John Idoko, AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos 930001, Nigeria

Sheena McCormack, MRC Clinical Trials Unit, London, London NW1 2DA, United Kingdom

John Idoko, National Agency for the Control of AIDS, Central Business District, Abuja 905001, Nigeria

Phyllis Kanki, Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115-5810, United States

Author contributions: Ladep NG, Muazu A, Cooke G and Idoko J designed, carried out part of clinical duties, analysed data; Agaba PA, Agbaji O and Ugoagwu P collated data, checked statistical correctness of the analysis helped with ethical processes and approved the use of data at study site; Ladep NG, Agaba PA, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J and Kanki P wrote up and approved final version of manuscript.

Supported by The United States Health Resources and Services Administration (U51HA02522-01-01); the Prevention of Liver Fibrosis and Carcinoma in Africa (PROLIFICA) project (EU-Framework 7); the United Kingdom National Institute for Healthcare Research (NIHR); and the London Clinic Research Fellowship Scheme

Correspondence to: Nimzing Gwamzhi Ladep, MD, Liver Unit, Imperial College London, St Mary’s Hospital Campus, 10^th Floor, QEQM Building, South Wharf Road, London W2 1NY, United Kingdom. n.ladep@imperial.ac.uk

Telephone: +44-203-3121909 Fax: +44-203-3121909

Received: August 28, 2012
Revised: December 7, 2012
Accepted: January 23, 2013
Published online: March 14, 2013

Core Tip